CALIFORNIA BANCORP (BCAL) Stock Fundamental Analysis
NASDAQ:BCAL - Nasdaq - US84252A1060 - Common Stock - Currency: USD
Taking everything into account, BCAL scores 4 out of 10 in our fundamental rating. BCAL was compared to 405 industry peers in the Banks industry. Both the profitability and financial health of BCAL have multiple concerns. BCAL is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
BCAL had positive earnings in the past year.
BCAL had a positive operating cash flow in the past year.
1.2 Ratios
BCAL's Return On Assets of -0.16% is on the low side compared to the rest of the industry. BCAL is outperformed by 93.48% of its industry peers.
The Return On Equity of BCAL (-1.39%) is worse than 93.48% of its industry peers.
BCAL's Return On Invested Capital of 0.96% is amongst the best of the industry. BCAL outperforms 99.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BCAL is in line with the industry average of 2.27%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.16% | ||
| ROE | -1.39% | ||
| ROIC | 0.96% |
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.51%
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of BCAL has declined.
With an excellent Operating Margin value of 40.68%, BCAL belongs to the best of the industry, outperforming 99.50% of the companies in the same industry.
BCAL's Operating Margin has improved in the last couple of years.
BCAL does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 40.68% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y19.91%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BCAL is destroying value.
BCAL has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BCAL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.82, we must say that BCAL is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of -0.82, BCAL belongs to the best of the industry, outperforming 99.00% of the companies in the same industry.
BCAL has a debt to FCF ratio of 214.63. This is a negative value and a sign of low solvency as BCAL would need 214.63 years to pay back of all of its debts.
The Debt to FCF ratio of BCAL (214.63) is worse than 83.96% of its industry peers.
A Debt/Equity ratio of 7.65 is on the high side and indicates that BCAL has dependencies on debt financing.
BCAL has a worse Debt to Equity ratio (7.65) than 99.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.65 | ||
| Debt/FCF | 214.63 | ||
| Altman-Z | -0.82 |
ROIC/WACC0.24
WACC4.05%
2.3 Liquidity
A Current Ratio of 0.04 indicates that BCAL may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.04, BCAL belongs to the top of the industry, outperforming 99.50% of the companies in the same industry.
BCAL has a Quick Ratio of 0.04. This is a bad value and indicates that BCAL is not financially healthy enough and could expect problems in meeting its short term obligations.
BCAL has a Quick ratio of 0.04. This is amongst the best in the industry. BCAL outperforms 99.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.04 | ||
| Quick Ratio | 0.04 |
3. Growth
3.1 Past
BCAL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -86.19%.
Measured over the past years, BCAL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -28.36% on average per year.
The Revenue has grown by 45.18% in the past year. This is a very strong growth!
The Revenue has been growing by 37.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-86.19%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%112.5%
Revenue 1Y (TTM)45.18%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%94.58%
3.2 Future
Based on estimates for the next years, BCAL will show a very strong growth in Earnings Per Share. The EPS will grow by 58.59% on average per year.
The Revenue is expected to grow by 22.58% on average over the next years. This is a very strong growth
EPS Next Y133.81%
EPS Next 2Y58.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year42.94%
Revenue Next 2Y22.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 21.70 indicates a rather expensive valuation of BCAL.
BCAL's Price/Earnings ratio is rather expensive when compared to the industry. BCAL is more expensive than 81.70% of the companies in the same industry.
BCAL is valuated rather cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 9.28, the valuation of BCAL can be described as reasonable.
BCAL's Price/Forward Earnings ratio is rather cheap when compared to the industry. BCAL is cheaper than 81.20% of the companies in the same industry.
BCAL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.7 | ||
| Fwd PE | 9.28 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BCAL indicates a rather cheap valuation: BCAL is cheaper than 99.25% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BCAL is valued a bit more expensive than the industry average as 75.44% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.79 | ||
| EV/EBITDA | 7.36 |
4.3 Compensation for Growth
BCAL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BCAL's earnings are expected to grow with 58.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y58.59%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BCAL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
15.84
-0.24 (-1.49%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners56.45%
Inst Owner Change-69.94%
Ins Owners15.93%
Ins Owner Change-0.75%
Market Cap511.16M
Analysts80
Price Target20.4 (28.79%)
Short Float %1.35%
Short Ratio4.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.46%
Min EPS beat(2)-96.35%
Max EPS beat(2)87.43%
EPS beat(4)1
Avg EPS beat(4)-7.83%
Min EPS beat(4)-96.35%
Max EPS beat(4)87.43%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-2.66%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-4.5%
Min Revenue beat(4)-8.42%
Max Revenue beat(4)-1.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.45%
PT rev (3m)13.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-6.95%
EPS NY rev (3m)-6.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-3.57%
Revenue NY rev (3m)-2.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.7 | ||
| Fwd PE | 9.28 | ||
| P/S | 3.43 | ||
| P/FCF | 28.79 | ||
| P/OCF | 28.05 | ||
| P/B | 1.03 | ||
| P/tB | 1.41 | ||
| EV/EBITDA | 7.36 |
EPS(TTM)0.73
EY4.61%
EPS(NY)1.71
Fwd EY10.78%
FCF(TTM)0.55
FCFY3.47%
OCF(TTM)0.56
OCFY3.57%
SpS4.62
BVpS15.43
TBVpS11.23
PEG (NY)0.16
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.16% | ||
| ROE | -1.39% | ||
| ROCE | 10.7% | ||
| ROIC | 0.96% | ||
| ROICexc | 0.98% | ||
| ROICexgc | 1.04% | ||
| OM | 40.68% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 11.9% |
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.51%
ROIC(5y)N/A
ROICexc(3y)1.54%
ROICexc(5y)N/A
ROICexgc(3y)1.61%
ROICexgc(5y)N/A
ROCE(3y)15.76%
ROCE(5y)N/A
ROICexcg growth 3Y37.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y36.48%
ROICexc growth 5YN/A
OM growth 3Y19.91%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.65 | ||
| Debt/FCF | 214.63 | ||
| Debt/EBITDA | 60.3 | ||
| Cap/Depr | 19.09% | ||
| Cap/Sales | 0.32% | ||
| Interest Coverage | 1.38 | ||
| Cash Conversion | 28.84% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.04 | ||
| Quick Ratio | 0.04 | ||
| Altman-Z | -0.82 |
F-Score4
WACC4.05%
ROIC/WACC0.24
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.19%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%112.5%
EPS Next Y133.81%
EPS Next 2Y58.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.18%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%94.58%
Revenue Next Year42.94%
Revenue Next 2Y22.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.71%
EBIT growth 3Y65.01%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-64.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.03%
OCF growth 3YN/A
OCF growth 5YN/A